Concord, OH, United States of America

Damodara Gopal

This inventor holds 1 USPTO granted patent. Top assignee: Pharmatrophix, Inc.. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Damodara Gopal

Introduction

Damodara Gopal is an accomplished inventor based in Concord, OH (US). He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and development of novel compounds.

Latest Patents

Gopal holds a patent for "Deuterated compounds useful for treating neurodegenerative diseases." This patent focuses on deuterated compounds that act as neurotrophin mimetics. The application details the treatment of disorders that involve the degradation or dysfunction of cells expressing p75 in mammals by administering an effective amount of these deuterated compounds. He has 1 patent to his name.

Career Highlights

Damodara Gopal is currently associated with Pharmatrophix, Inc., where he continues to advance his research in the pharmaceutical field. His work is pivotal in developing therapies that could potentially improve the quality of life for individuals suffering from neurodegenerative diseases.

Conclusion

Damodara Gopal's innovative contributions to the treatment of neurodegenerative diseases highlight his role as a significant inventor in the pharmaceutical industry. His research and patents pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…